{"id":"https://genegraph.clinicalgenome.org/r/61ad3529-b9e2-4b94-a388-3c11b1cb5144v1.0","type":"EvidenceStrengthAssertion","dc:description":"The relationship between TMEM43 and arrhythmogenic right ventricular dysplasia (autosomal dominant) was evaluated using the ClinGen Clinical Validity Framework as of July 10th, 2019. Variants in TMEM43 were first reported in humans with this disease as early as 2008 (Merner et al., PMID 18313022). At least 9 variants (mostly missense) have been reported in humans. However, the pathogenicity of most of the variants is unknown.  The majority of genetic evidence comes from case-level data and segregation data for one founder variant, p.Ser358Leu, which has been reported in more than 20 families with ARVC and occurred de novo in one individual (Merner et al., 2008, PMID 18313022; Christensen et al. 2011, PMID 21214875; Baskin et al., 2013, PMID 23812740; Hodgkinson et al., 2013, PMID 22725725; Milting et al., 2014, PMID 24598986). This gene-disease relationship is also supported by an animal model, expression stuies, and in vitro assays. In summary, TMEM43 is definitively associated with autosomal dominant arrhythmogenic right ventricular dysplasia . This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen  Arrythmogenic Right Ventricular Cardiomyopathy Gene Curation Expert Panel on October 26, 2018 (SOP Version 6).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/61ad3529-b9e2-4b94-a388-3c11b1cb5144","GCISnapshot":"https://genegraph.clinicalgenome.org/r/675dc788-9749-413f-93ce-8c1fc3adbe84","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/675dc788-9749-413f-93ce-8c1fc3adbe84_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10003","date":"2018-10-26T16:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/675dc788-9749-413f-93ce-8c1fc3adbe84_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10003","date":"2020-09-16T19:22:58.127Z","role":"Publisher"},{"agent":"https://genegraph.clinicalgenome.org/agent/10018","role":"SecondaryContributor"}],"curationReasonDescription":"","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/675dc788-9749-413f-93ce-8c1fc3adbe84_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/675dc788-9749-413f-93ce-8c1fc3adbe84_ad_dn_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cc5cc5ba-bdfc-4bba-b377-7d0905916f4f_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Paternity confirmed.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/af943a2c-1a07-47e4-b3d6-b5e5ffe59b24","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23812740","rdfs:label":"De novo S358L","ageType":"AgeAtReport","ageUnit":"Years","ageValue":43,"detectionMethod":"Mutational screening by direct sequence analysis of all exons and flanking introns of DSP, PKP2, DSC2, DSG2, and TMEM43.","phenotypes":["obo:HP_0002119","obo:HP_0002375","obo:HP_0031317"],"previousTesting":false,"previousTestingDescription":"","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/cc5cc5ba-bdfc-4bba-b377-7d0905916f4f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23812740","allele":{"id":"https://genegraph.clinicalgenome.org/r/b07146ff-882e-475c-90e8-8305b32b016e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_024334.2(TMEM43):c.1073C>T (p.Ser358Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/734"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes"}}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":3}],"specifiedBy":"GeneValidityOverallAutosomalDominantDeNovoVariantEvidenceCriteria","strengthScore":3},{"id":"https://genegraph.clinicalgenome.org/r/675dc788-9749-413f-93ce-8c1fc3adbe84_ad_other_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/eb413202-02dc-46b3-8bff-8a58df0668b2_proband_score_evidence_line","type":"EvidenceLine","dc:description":"This variant is at a frequency of 0.03553 in European (Finnish) population in gnomAD.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c4233f7f-5eab-4a85-a61a-02b08256af55","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23161701","rdfs:label":"B12","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"Bidirectional sequencing of TMEM43.","phenotypes":["obo:HP_0001279","obo:HP_0010872","obo:HP_0001962"],"previousTesting":true,"previousTestingDescription":"\"Negative for mutations in desmosomal ARVC genes.\"","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/eb413202-02dc-46b3-8bff-8a58df0668b2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23161701","allele":{"id":"https://genegraph.clinicalgenome.org/r/76dd8aa1-b85c-4dda-a277-7907b837a6a2","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_024334.2(TMEM43):c.934C>T (p.Arg312Trp)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/36873"}}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/ec3671a3-6f4c-4384-aff8-48acf98beb24_proband_score_evidence_line","type":"EvidenceLine","dc:description":"European (Finnish) frequency of 0.03553 in gnomAD.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5b2e00d7-8aad-4501-838b-5c8c97e628bf","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23812740","rdfs:label":"RW","ageType":"AgeAtReport","ageUnit":"Years","ageValue":31,"detectionMethod":"Mutational screening by direct sequence analysis of all exons and flanking introns of DSP, PKP2, DSC2, DSG2, and TMEM43.","phenotypes":["obo:HP_0011841","obo:HP_0002013","obo:HP_0004756"],"previousTesting":false,"previousTestingDescription":"","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/ec3671a3-6f4c-4384-aff8-48acf98beb24_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23812740","allele":{"id":"https://genegraph.clinicalgenome.org/r/76dd8aa1-b85c-4dda-a277-7907b837a6a2"}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/bb242adb-7478-4d00-aecf-04954cc3a0f6_proband_score_evidence_line","type":"EvidenceLine","dc:description":"This variant is at a frequency of 0.01076 with 3 homozygotes in East Asian population.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d9d500d1-3e2d-4e43-b69b-026776ece361","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23812740","rdfs:label":"YH","ageType":"AgeAtReport","ageUnit":"Years","ageValue":12,"detectionMethod":"Mutational screening by direct sequence analysis of all exons and flanking introns of DSP, PKP2, DSC2, DSG2, and TMEM43.","ethnicity":{"id":"cg:NotHispanicOrLatino"},"phenotypeFreeText":"Patients referred to high-risk hereditary heart disorders clinic for assessment of possible ARVC.","previousTesting":false,"previousTestingDescription":"","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/bb242adb-7478-4d00-aecf-04954cc3a0f6_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23812740","allele":{"id":"https://genegraph.clinicalgenome.org/r/bd4b11d6-5416-41ef-8dfa-163f90ad6bde","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_024334.2(TMEM43):c.1111T>C (p.Tyr371His)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/46140"}}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/952e4e2f-7876-433d-8b4a-d15cc82591b3_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Frequency in South Asian population is 0.006432 with 1 homozygote in gnomAD.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4bad2626-5733-44b8-8953-bf1071f466b9","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23812740","rdfs:label":"TS","ageType":"AgeAtReport","ageUnit":"Years","ageValue":16,"detectionMethod":"Mutational screening by direct sequence analysis of all exons and flanking introns of DSP, PKP2, DSC2, DSG2, and TMEM43.","phenotypes":["obo:HP_0004756","obo:HP_0001962","obo:HP_0006956","obo:HP_0100749"],"previousTesting":false,"previousTestingDescription":"","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/952e4e2f-7876-433d-8b4a-d15cc82591b3_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23812740","allele":{"id":"https://genegraph.clinicalgenome.org/r/4c86c648-762d-4c54-a115-63f4f213f334","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_024334.2(TMEM43):c.829A>T (p.Thr277Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/165456"}}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/f012788e-95f5-495e-9e54-6f769eb5a599_proband_score_evidence_line","type":"EvidenceLine","dc:description":"No functional evidence. This variant may be too common to count (0.001121 in European, Non-Finnish).","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0f35c5f3-5a23-4847-ac8f-56d1ff4b468d","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23161701","rdfs:label":"UK-5, A4","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"Bidirectional sequencing of TMEM43.","phenotypeFreeText":"Met diagnostic criteria for ARVC based on the International Society and Federation of Cardiology or modified criteria.","previousTesting":true,"previousTestingDescription":"\"Negative for mutations in desmosomal ARVC genes.\"","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/f012788e-95f5-495e-9e54-6f769eb5a599_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23161701","allele":{"id":"https://genegraph.clinicalgenome.org/r/eec6155f-e798-47dc-a872-e00216c4361f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_024334.2(TMEM43):c.424G>A (p.Glu142Lys)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/46147"}}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/1edda27c-6579-4424-8540-e3cf8d23c38a_proband_score_evidence_line","type":"EvidenceLine","dc:description":"The authors predict that it affects the splice donor site of intron 8, but there are no functional studies. It is at a frequency of 0.000346 in ExAC. ClinVar has it listed as benign/likely benign with several submitters.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/801ba6c0-088d-49f9-9bd9-38a1078f6ff1","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21214875","rdfs:label":"Proband A","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":59,"detectionMethod":"Entire gene sequenced.","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"PCR","phenotypes":["obo:HP_0004756","obo:HP_0005133","obo:HP_0031317","obo:HP_0010872"],"previousTesting":true,"previousTestingDescription":"Negative for mutations in DSC2, DSG2, DSP, JUP, PKP2, TGFb3, or large genomic rearrangements.","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/1edda27c-6579-4424-8540-e3cf8d23c38a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21214875","allele":{"id":"https://genegraph.clinicalgenome.org/r/30b8601e-7865-418d-91dc-72cb8d320b0e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_024334.2(TMEM43):c.705+7G>A","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/46152"}}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/23c9d889-0907-4d25-97ab-77d3826d91e8_proband_score_evidence_line","type":"EvidenceLine","dc:description":"This is a well-known founder variant in Newfoundland and is fully penetrant with a severe phenotype. FUnctional studies show that it reduces conduction velocity, increases the stiffness cell nuclei and alters gap junction function (Siragam, 2014, Miltin, 2015).","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e0bbf081-f4da-4df7-84cf-1e7651339656","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18313022","rdfs:label":"AR-9: VII-7","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"Comparison of the ARVD5 ancestral haplotypes across clinically affected subjects reduced the region to an interval containing 20 annotated genes. Bidirectional resequencing and segregation analysis in an 8 generation family of the 20 candidates allowed them to narrow it down to a single variant in TMEM43.","ethnicity":{"id":"cg:NotHispanicOrLatino"},"phenotypeFreeText":"These families were determined to have ARVC on the basis of clinical testing with established criteria,  postmortem pathology, and an autosomal-dominant pattern of inheritance","previousTesting":false,"previousTestingDescription":"","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/23c9d889-0907-4d25-97ab-77d3826d91e8_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18313022","allele":{"id":"https://genegraph.clinicalgenome.org/r/b07146ff-882e-475c-90e8-8305b32b016e"}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/e7f0e3a0-6ccd-438b-ae61-0fa03f0d0d32_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Founder variant.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b45f33b6-e36f-47d4-887f-2a4ac459cef6","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24598986","rdfs:label":"III-1","ageType":"AgeAtReport","ageUnit":"Years","ageValue":74,"detectionMethod":"Mutations screening done by DHPLC.","phenotypes":["obo:HP_0004756","obo:HP_0031317","obo:HP_0001645","obo:HP_0100660"],"previousTesting":true,"previousTestingDescription":"Negative for mutations in DSC2, DSG2, PKP2, JUP, DSP, and DES.","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/e7f0e3a0-6ccd-438b-ae61-0fa03f0d0d32_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24598986","allele":{"id":"https://genegraph.clinicalgenome.org/r/b07146ff-882e-475c-90e8-8305b32b016e"}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.25},{"id":"https://genegraph.clinicalgenome.org/r/1ab1cfbb-8982-45c8-abe5-c1a7f9729ffc_proband_score_evidence_line","type":"EvidenceLine","dc:description":"This variant is at a frequency of 0.03553 in European (Finnish) population in gnomAD.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1839f240-e2b1-48d0-b8f7-ec84e964b996","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23161701","rdfs:label":"A2","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"Bidirectional sequencing of TMEM43.","phenotypeFreeText":"Regional hypokinesia at subtricuspid region, LV and RV trabeculations","phenotypes":["obo:HP_0002119","obo:HP_0001712"],"previousTesting":true,"previousTestingDescription":"\"Negative for mutations in desmosomal ARVC genes.\"","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/1ab1cfbb-8982-45c8-abe5-c1a7f9729ffc_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23161701","allele":{"id":"https://genegraph.clinicalgenome.org/r/76dd8aa1-b85c-4dda-a277-7907b837a6a2"}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/372be07c-840f-4c76-9ffd-c7589c66e371_proband_score_evidence_line","type":"EvidenceLine","dc:description":"No functional evidence. This variant may be too common to count (0.001121 in European, Non-Finnish).","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/967a4495-175a-4169-8bba-bfd4556d60e3","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23161701","rdfs:label":"UK-6, B4","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"Bidirectional sequencing of TMEM43.","phenotypeFreeText":"Met diagnostic criteria for ARVC based on the International Society and Federation of Cardiology or modified criteria.","previousTesting":true,"previousTestingDescription":"\"Negative for mutations in desmosomal ARVC genes.\"","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/372be07c-840f-4c76-9ffd-c7589c66e371_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23161701","allele":{"id":"https://genegraph.clinicalgenome.org/r/eec6155f-e798-47dc-a872-e00216c4361f"}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/e22b3899-97d4-4041-bc91-f4275eca09a0_proband_score_evidence_line","type":"EvidenceLine","dc:description":"This is a common pathogenic founder variant.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dcaf5d6b-20aa-4108-8bf9-b368527e57da","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21214875","rdfs:label":"Proband B","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":49,"detectionMethod":"Entire gene sequenced.","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"PCR","phenotypes":["obo:HP_0010872","obo:HP_0031317","obo:HP_0005133","obo:HP_0011675"],"previousTesting":true,"previousTestingDescription":"Negative for mutations in DSC2, DSG2, DSP, JUP and PKP2 and genomic rearrangements.","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/e22b3899-97d4-4041-bc91-f4275eca09a0_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21214875","allele":{"id":"https://genegraph.clinicalgenome.org/r/b07146ff-882e-475c-90e8-8305b32b016e"}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.25},{"id":"https://genegraph.clinicalgenome.org/r/fe825f32-99d3-4d38-a200-2cff5fc25ee2_proband_score_evidence_line","type":"EvidenceLine","dc:description":"This variant is at a frequency of 0.03553 in European (Finnish) population in gnomAD.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c2b6f5b6-8829-4f70-9a00-2af7139e202e","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23161701","rdfs:label":"UK-3, B1","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"Bidirectional sequencing of TMEM43.","phenotypeFreeText":"Met diagnostic criteria for ARVC based on the International Society and Federation of Cardiology or modified criteria. Ventricular ablation, implantable cardioverter deibrillator.","previousTesting":true,"previousTestingDescription":"\"Negative for mutations in desmosomal ARVC genes.\"","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/fe825f32-99d3-4d38-a200-2cff5fc25ee2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23161701","allele":{"id":"https://genegraph.clinicalgenome.org/r/76dd8aa1-b85c-4dda-a277-7907b837a6a2"}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/4358c50a-3c0a-4be9-90a7-ee05af6b7c55_proband_score_evidence_line","type":"EvidenceLine","dc:description":"There were 5 patients with the Newfoundland founder variant.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5c70e3a3-6e3e-49b6-b74b-9b6ec38e7afe","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23812740","rdfs:label":"S358L Patients 1-5","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"Mutational screening by direct sequence analysis of all exons and flanking introns of DSP, PKP2, DSC2, DSG2, and TMEM43.","phenotypeFreeText":"Patients referred to high-risk hereditary heart disorders clinic for assessment of possible ARVC.","previousTesting":false,"previousTestingDescription":"","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/4358c50a-3c0a-4be9-90a7-ee05af6b7c55_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23812740","allele":{"id":"https://genegraph.clinicalgenome.org/r/b07146ff-882e-475c-90e8-8305b32b016e"}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/83bd3211-4aa7-4087-8c72-dff987c739bd_proband_score_evidence_line","type":"EvidenceLine","dc:description":"No functional evidence. One variant is at a frequency of 0.001044 in East Asian population in gnomAD and the other is at 0.005246. These may be too high to count.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/87a5a299-7dc3-4cd2-9732-f5027e6a4d35","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26840987","rdfs:label":"Fetal case","ageType":"AgeAtDiagnosis","ageUnit":"Days","detectionMethod":"No specific information on genotyping method.","phenotypes":["obo:HP_0011713","obo:HP_0001640","obo:HP_0100572","obo:HP_0006682"],"previousTesting":false,"previousTestingDescription":"","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/83bd3211-4aa7-4087-8c72-dff987c739bd_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26840987","allele":[{"id":"https://genegraph.clinicalgenome.org/r/a4c2fc71-91b1-43ac-8f6b-29bc2e9086f3","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000003.12:g.14130924G>A","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA052413"}},{"id":"https://genegraph.clinicalgenome.org/r/f74943eb-824a-4833-8ef5-8a5067008083","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_024334.2(TMEM43):c.896G>C (p.Arg299Thr)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/202109"}}],"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/8a6ece2a-f4de-4dd5-a9b0-07c5513182d0_proband_score_evidence_line","type":"EvidenceLine","dc:description":"The frequency of this variant may be too high to count: 0.001121 in European (Non-Finnish).","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9e95c302-b3ce-41b8-96d5-016acfc589bd","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23812740","rdfs:label":"EK","ageType":"AgeAtReport","ageUnit":"Years","ageValue":47,"detectionMethod":"Mutational screening by direct sequence analysis of all exons and flanking introns of DSP, PKP2, DSC2, DSG2, and TMEM43.","phenotypes":["obo:HP_0100660","obo:HP_0010872"],"previousTesting":false,"previousTestingDescription":"","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/8a6ece2a-f4de-4dd5-a9b0-07c5513182d0_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23812740","allele":{"id":"https://genegraph.clinicalgenome.org/r/eec6155f-e798-47dc-a872-e00216c4361f"}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/35cd4811-5657-4c5d-85d9-58d5e330fbc2_proband_score_evidence_line","type":"EvidenceLine","dc:description":"No functional evidence. At a frequency of 0.001381 in Ashkenazi Jewish population.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/80c9312b-3f27-4446-8434-aa29eec827f1","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23812740","rdfs:label":"AT","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"Mutational screening by direct sequence analysis of all exons and flanking introns of DSP, PKP2, DSC2, DSG2, and TMEM43.","phenotypes":["obo:HP_0010872","obo:HP_0002119","obo:HP_0004756"],"previousTesting":false,"previousTestingDescription":"","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/35cd4811-5657-4c5d-85d9-58d5e330fbc2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23812740","allele":{"id":"https://genegraph.clinicalgenome.org/r/5e65fb4b-fc58-48e5-bb89-0a16789cb691","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_024334.2(TMEM43):c.169G>A (p.Ala57Thr)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/88981"}}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.1}],"specifiedBy":"GeneValidityOverallAutosomalDominantOtherVariantEvidenceCriteria","strengthScore":3.6},{"id":"https://genegraph.clinicalgenome.org/r/675dc788-9749-413f-93ce-8c1fc3adbe84_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bf9fb6d5-96fe-48a9-a603-d8ced9537e56_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24598986","rdfs:label":"German ARVC family","estimatedLodScore":1.81,"family":{"id":"https://genegraph.clinicalgenome.org/r/bf9fb6d5-96fe-48a9-a603-d8ced9537e56","type":"Family","rdfs:label":"German ARVC family","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/b45f33b6-e36f-47d4-887f-2a4ac459cef6"}},"meetsInclusionCriteria":true,"phenotypeFreeText":"","phenotypePositiveAllelePositive":7,"phenotypes":["obo:HP_0100660","obo:HP_0001645","obo:HP_0031317","obo:HP_0004756"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/b45f33b6-e36f-47d4-887f-2a4ac459cef6"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/424af4e7-596d-4225-8965-a81d87190408_proband_segregation","type":"FamilyCosegregation","dc:description":"This is a common variant and not enough unaffected members were tested.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23161701","rdfs:label":"UK-1","estimatedLodScore":1.81,"family":{"id":"https://genegraph.clinicalgenome.org/r/424af4e7-596d-4225-8965-a81d87190408","type":"Family","rdfs:label":"UK-1","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/c4233f7f-5eab-4a85-a61a-02b08256af55"}},"meetsInclusionCriteria":false,"phenotypeFreeText":"Met diagnostic criteria for ARVC based on the International Society and Federation of Cardiology or modified criteria.","phenotypePositiveAllelePositive":4,"proband":{"id":"https://genegraph.clinicalgenome.org/r/c4233f7f-5eab-4a85-a61a-02b08256af55"}},{"id":"https://genegraph.clinicalgenome.org/r/d8ff5e13-6551-41ab-abde-497b90a82349_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18313022","rdfs:label":"Families 1-15","estimatedLodScore":24.68,"family":{"id":"https://genegraph.clinicalgenome.org/r/d8ff5e13-6551-41ab-abde-497b90a82349","type":"Family","rdfs:label":"Families 1-15","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/e0bbf081-f4da-4df7-84cf-1e7651339656"}},"meetsInclusionCriteria":true,"phenotypeFreeText":"These families were determined to have ARVC on the basis of clinical testing with established criteria,  postmortem pathology, and an autosomal-dominant pattern of inheritance","phenotypePositiveAllelePositive":83,"proband":{"id":"https://genegraph.clinicalgenome.org/r/e0bbf081-f4da-4df7-84cf-1e7651339656"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/7e939872-0709-42d4-8527-377bf6952354_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23161701","rdfs:label":"UK-2","family":{"id":"https://genegraph.clinicalgenome.org/r/7e939872-0709-42d4-8527-377bf6952354","type":"Family","rdfs:label":"UK-2","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/1839f240-e2b1-48d0-b8f7-ec84e964b996"}},"phenotypeFreeText":"Met diagnostic criteria for ARVC based on the International Society and Federation of Cardiology or modified criteria.","phenotypePositiveAllelePositive":1,"proband":{"id":"https://genegraph.clinicalgenome.org/r/1839f240-e2b1-48d0-b8f7-ec84e964b996"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":8.1},{"id":"https://genegraph.clinicalgenome.org/r/675dc788-9749-413f-93ce-8c1fc3adbe84_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/675dc788-9749-413f-93ce-8c1fc3adbe84_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b46cdc12-860b-4d45-9da9-0a90dbf75d72","type":"EvidenceLine","dc:description":"TMEM43 S358L-KI mice showed classic features of ARVC: structural abnormalities and cardiac fibrosis.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fa649007-918e-4d2b-b55b-68633f0184d6","type":"Finding","dc:description":"S358L heterozygous adult male mice showed higher level of LVEDD (p-value 0.0435) and lower level of posterior wall thickness in systole (p-value 0.0125) indicating enlarged cardiac chambers and thinner ventricular walls. After tense running, 1/4 KI mice had ECG abnormality and 1/8 had sudden cardiac death after tense exercise on running wheel (0 wild type). Ratio of heart weight to body weight increased in KI group compared to control. Fibrosis and fat accumulation were elevated in KI mouse hearts. RNA-seq showed that KI mice had higher expression of markers of fibrosis and adipogenesis.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29980933","rdfs:label":"S358L Mouse Model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":3},{"id":"https://genegraph.clinicalgenome.org/r/989e4c2c-f059-4d69-a705-a7d9ddb2a6dc","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4e89c4dd-c224-4dfa-b1f6-abc9f78be252","type":"Finding","dc:description":"Electrograms and conduction velocities were recorded from control, TMEM43-WT, and TEMEM43-S358L cell cultures. Control and wild type cells beat with regular, synchronous rhythms, while the mutant cells showed a slower, irregular rhythm.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25343256","rdfs:label":"HL-1 atrial cardiomyocytes","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityCellCultureModelOrganismCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":4},{"id":"https://genegraph.clinicalgenome.org/r/675dc788-9749-413f-93ce-8c1fc3adbe84_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/95393bf0-bb83-43ed-9090-21b0db47b6b5","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/73641512-37a0-4d90-91ea-6d5971e60deb","type":"Finding","dc:description":"Immunohistochemical analysis of the myocardium showed reduced signal in the ARVC patients with TMEM43 variants. In the p.S58L mutation carriers, the reduction was most pronounced and the staining pattern had a more cytoplasmic distribution.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21214875","rdfs:label":"Christensen 2011 Expression","demonstrates":{"id":"cg:GeneExpressionB"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/b467bcf5-c89f-40e3-ad2d-c3ad19ba4934","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/003bf646-0a23-421d-88dc-5cbda61bbf30","type":"Finding","dc:description":"cDNA extracted from heart tissue from both the left and right ventricle of an affected subject (AR13) and a heart biopsy from a control subject showed expression in both.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18313022","rdfs:label":"Merner 2008 Expression","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":5}],"evidenceStrength":"Definitive","sequence":691,"specifiedBy":"GeneValidityCriteria7","strengthScore":13.1,"subject":{"id":"https://genegraph.clinicalgenome.org/r/fU8SQpH6HCw","type":"GeneValidityProposition","disease":"obo:MONDO_0011459","gene":"hgnc:28472","modeOfInheritance":"obo:HP_0000006"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_675dc788-9749-413f-93ce-8c1fc3adbe84-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}